Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.
ELIXIR MD Inc., a medical technology company pioneering proprietary technologies and treatment protocols for post-surgical ...
Enter your email and we’ll send a secure one-click link to sign in. Please enter a valid email address By clicking on any of the sign up options below, you confirm ...
The MarketWatch News Department was not involved in the creation of this content. IRVINE, Calif. and MEXICO CITY, July 22, 2025 /PRNewswire/ -- ELIXIR MD, Inc., a pioneer in advanced aesthetic ...
Elixir Medical’s investigational Dynamx Sirolimus-Eluting Coronary Bioadaptor System aims to improve percutaneous coronary intervention (PCI) by bettering the technology clinicians use to keep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results